Abdul Karim Khalid | Host Genetics | Best Paper Award

Published on by Genetics and Genomics

Mr. Abdul Karim Khalid | Host Genetics | Best Paper Award

Huazhong Agricultural University | China

Abdul Karim Khalid is a veterinary researcher specializing in preventive veterinary medicine, microbial pathogenesis, and host–microbe interactions, currently based in Wuhan, China. He earned his Master’s degree in Preventive Veterinary Medicine from Huazhong Agricultural University with a strong academic record, where his thesis focused on elucidating the role of the secreted protein MbovP537 as a virulence factor and diagnostic antigen in Mycoplasma bovis pathogenesis. His research integrates molecular microbiology, immunology, and translational One Health approaches, encompassing gene cloning, protein expression, mammalian cell culture, and advanced immunological assays. Abdul has contributed to multiple high-impact peer-reviewed publications in journals such as Veterinary Microbiology, eLife, Cells, and Frontiers in Immunology. He also holds a Doctor of Veterinary Medicine degree from Gomal University, Pakistan, and brings valuable clinical experience alongside strong bioinformatics and statistical analysis skills.

Citation Metrics (Scopus)

30
20
10
5
0

Citations
6

Documents
3

h-index
2

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile
 View GoogleScholar Profile

Helala AlShehri | Cancer Genetics | Research Excellence Award

Published on by Genetics and Genomics

Assist. Prof. Dr. Helala AlShehri | Cancer Genetics | Research Excellence Award

Jubail Industrial College | Saudi Arabia

Assist. Prof. Dr. Helala Mohammad AlShehri is an Assistant Professor of Computer Science and Deputy for Planning and Development at Jubail Industrial College, Saudi Arabia. She earned her PhD in Computer Science from King Saud University and brings together strong academic leadership with advanced research expertise in artificial intelligence and deep learning. Dr. AlShehri has held several senior administrative roles, including department chair and head of student and academic affairs, contributing significantly to institutional planning, quality assurance, and academic accreditation. Her research focuses on AI-driven medical image analysis, particularly histopathological image classification for cancer diagnosis, explainable AI, and computer-aided decision support. She has published nine peer-reviewed articles in SCI- and Scopus-indexed journals, with over 140 citations. Dr. AlShehri actively collaborates with national and international researchers and serves as a peer reviewer for leading AI and medical imaging journals.

Citation Metrics (Scopus)

1000
100
10
5
0

Citations
97

Documents
6

h-index
5

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile View Google Scholar Profile

Featured Publications

Jacob Raber | Cancer Genetics | Research Excellence Award

Published on by Genetics and Genomics

Prof. Jacob Raber | Cancer Genetics | Research Excellence Award

OHSU | United States

Prof. Jacob Raber, Ph.D., is a distinguished Professor with interdisciplinary expertise spanning Behavioral Neuroscience, Neurology, Psychiatry, and Radiation Medicine. He serves as an Affiliated Scientist in the Division of Neuroscience at the Oregon National Primate Research Center (ONPRC), Oregon Health & Science University (OHSU), and holds a courtesy appointment as Professor of Pharmaceutical Sciences at Oregon State University. Dr. Raber earned his BSc in Chemistry and MSc in Pharmacochemistry from the Free University of Amsterdam, where his early research focused on β2-adrenergic receptor desensitization, complemented by training in immunochemistry and Yiddish language and literature. He completed his Ph.D. in Molecular Genetics and Virology at the Weizmann Institute of Science in Israel, investigating interferon-regulated pathways under the mentorship of Dr. Michel Revel. His work integrates molecular genetics with translational neuroscience to advance understanding of brain function and disease.

Citation Metrics (Scopus)

20000
15000
10000
500
0

Citations
15,411

Documents
304

h-index
63

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile

Featured Publications

Yuhui Sun | Gene Therapy | Excellence in Research

Published on by Genetics and Genomics

Prof. Dr. Yuhui Sun | Gene Therapy | Excellence in Research

Huazhong University of Science and Technology | China

Prof. Dr. Yuhui Sun is a Professor at Huazhong University of Science and Technology, China. He received his Ph.D. from Shanghai Jiao Tong University and conducted postdoctoral research at the University of Cambridge in Professor Peter F. Leadlay’s group. He served as a Professor at Wuhan University before joining HUST. His research focuses on microbial natural product discovery, biosynthesis, and the development of advanced genetic and genome-editing tools, particularly CRISPR-Cas9–based base editors. Professor Sun has led eight major national and provincial research projects, published 69 SCI-indexed papers with an H-index of 25 and over 1,900 citations, authored a Springer Nature book chapter, and holds nine international and Chinese patents. He has extensive industry collaboration experience, serves on multiple international editorial boards, and is a Fellow of the Royal Society of Chemistry (UK). Internationally recognized for elucidating complex biosynthetic mechanisms and creating hybrid microbial medicines, he has also developed widely adopted genome-editing technologies shared with over 80 research groups worldwide.

Citation Metrics (Scopus)

2400
1800
1200
  600
  0

Citations
2,070

Documents
72

h-index
27

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile

Featured Publications

Hongzhou LU | Host Genetics | Research Excellence Award

Published on by Genetics and Genomics

Prof. Hongzhou LU | Host Genetics | Research Excellence Award

Shenzhen Third People's Hospital | China

Prof. Lu Hongzhou is a distinguished clinician–scientist and leader in infectious diseases, currently serving as Director of Shenzhen Third People’s Hospital (Second Hospital Affiliated to Southern University of Science and Technology), Director of the National Clinical Research Center for Infectious Diseases, Deputy Dean of the Medical School of Southern University of Science and Technology, and Full Professor of Internal Medicine. He received his MBBS from Bengbu Medical College and PhD in Internal Medicine from Shanghai Medical University, and completed postdoctoral training at Vanderbilt University Medical Center, USA. Prof. Lu has dedicated over three decades to clinical practice, education, and research in infectious diseases, with major contributions to HIV/AIDS functional cure, emerging and re-emerging infections, rational antibiotic use, and severe respiratory and CNS infections. He has published over 500 peer-reviewed papers in leading journals including NEJM, Nature, and Signal Transduction and Targeted Therapy, authored 15 books, holds 15 patents, and has led more than 60 major research grants. Recognized globally, he is a Fellow of the American Academy of Microbiology, listed among Stanford University’s World’s Top 2% Scientists (2021–2024), and ranked in the top 0.05% scholars worldwide by ScholarGPS. Prof. Lu holds key advisory roles with the World Health Organization and national health authorities, has led responses to major public health emergencies including COVID-19 and Mpox, and is Editor-in-Chief of iLABMED. His work has been honored with numerous national and international awards for scientific, clinical, and public health excellence.

Citation Metrics (Scopus)

20000
10000
1000
500
0

Citations
19,373

Documents
579

h-index
49

Citations

Documents

h-index


View Scopus Profile

Featured Publications

Nasrin Samadyar | Cancer Genetics | Research Excellence Award

Published on by Genetics and Genomics

Dr. Nasrin Samadyar | Cancer Genetics | Research Excellence Award

Kermanshah University of Technology, Kermanshah | Iran

Dr. Nasrin Samadyar, born on 17 June 1989 in Karaj, Alborz Province, Iran, is an Iranian applied mathematician specializing in numerical analysis, stochastic differential equations, and meshfree computational methods. She earned her BSc in Applied Mathematics from Kharazmi University, followed by an MSc from Amirkabir University of Technology and a PhD in Applied Mathematics (Numerical Analysis) from Malayer University, where her doctoral research focused on meshfree radial basis function methods for solving stochastic integral equations. She later completed a postdoctoral fellowship in Mathematics at Alzahra University, concentrating on numerical solutions of stochastic differential and partial differential equations. A dedicated educator, she has taught courses such as Numerical Analysis, Linear Optimization, Calculus, and Numerical Linear Algebra. Samadyar has authored numerous high-impact journal publications spanning stochastic integral equations, fractional models, operational matrix methods, wavelet techniques, and meshless approaches, contributing significantly to computational mathematics. She also serves as a reviewer for leading international journals, including the International Journal of Biomathematics, Journal of Computational and Applied Mathematics, Applied Mathematics and Computation, and Soft Computing. A member of Iran's National Elites Foundation, she has supervised graduate research on numerical and stochastic equation-solving techniques and participated in advanced mathematical projects, including implicit meshless methods for fractional stochastic Tricomi-type equations. Proficient in MATLAB, MAPLE, MATHEMATICA, LaTeX, and C++, Samadyar continues to advance research in applied and stochastic mathematics through rigorous analysis, innovative numerical schemes, and interdisciplinary applications.

Profiles: Scopus | Google Scholar

Featured Publications

"A new scheme for solving nonlinear Stratonovich Volterra integral equations via Bernoulli’s approximation, Appl", F. Mirzaee, N. Samadyar, S.F. Hosseini., 2025

"Euler polynomial solutions of nonlinear stochastic Ito-Volterra integral equations, J. Comput. Appl",F. Mirzaee, N. Samadyar, S.F. Hosseini., 2025

"Application of orthonormal Bernstein polynomials to construct a efficient scheme for solving fractional stochastic integro-differential equation, Optik Int. J. Light Electron Opt", F. Mirzaee, N. Samadyar., 2025

"Numerical solution of nonlinear stochastic Ito-Volterra integral equations driven by fractional Brownian motion, Math. Meth. Appl",F. Mirzaee, N. Samadyar., 2025

Xinghua Pan | Next-Generation Sequencing | Research Excellence Award

Published on by Genetics and Genomics

Prof. Xinghua Pan | Next-Generation Sequencing | Research Excellence Award

Macau University of Science and Technology | China

Prof. Xinghua (Victor) Pan, PhD, MD, is a distinguished scholar in single-cell technology, genome medicine, cancer biology, regenerative medicine, and multi-omics bioinformatics, currently serving as a Professor at the Precision Regenerative Medicine Research Centre (PRMRC) in the Medical Science Division of Macau University of Science and Technology (MUST), with a secondary affiliation at the State Key Laboratory of Quality Research in Chinese Medicine. A doctoral supervisor in Biomedical Science and Pharmacy programs at MUST, Dr. Pan previously served as Chairman and Professor of Biochemistry and Molecular Biology at Southern Medical University (SMU), where he founded and led the Guangdong Provincial Key Laboratory of Single Cell Technology and Application and held multiple adjunct roles across major hospitals, universities, and national laboratories. With a career spanning Yale University—where he advanced from Associate Research Scientist to Research Scientist and PI-and leadership positions in molecular genomics companies, Dr. Pan brings decades of expertise shaped by rigorous training at Southern Medical University, Fudan University, CAMS & PUMC, and Yale University, complemented by international fellowships at Peking University, Melbourne University, the Ludwig Institute, and Cold Spring Harbor Laboratory. Renowned for pioneering single-cell sequencing innovations-including multiomics, copy-number, methylome, transcriptome, telomere, and multiplexing technologies-he has applied these breakthroughs to major biomedical challenges across cancer, stem cells, organoids, aging, infectious diseases, immunology, brain disorders, and precision medicine. Dr. Pan has authored over 160 publications in high-impact journals such as Nature, PNAS, Advanced Science, Nucleic Acids Research, and Nature Communications, accumulating more than 8,500 citations and an H-index of 40, alongside 15 issued patents in the U.S. and China. His work has been supported by national and international foundations including NSFC, NIH, NSF, MOST, and leading provincial and municipal programs. A dedicated educator who has trained over 60 researchers and taught nearly 10,000 students, he also serves as an Associate Editor of Precision Clinical Medicine and Monocytomics, reviewer for more than 30 top journals, and evaluator for major grant agencies and academic degree committees. As an organizer and keynote speaker at over 100 global conferences, including co-chairing the International Conference on Single Cell and Spatial Omics (TICSSO), Dr. Pan has also held leadership roles in multiple scientific societies and earned numerous accolades such as UICC and CSHL Scholarships, PolyGenomics Fellowship, VEBLEO Fellow, Nanjing Leading Talent, Guangzhou High-Level Talent, Ganpo Distinguished Professor, and the CastUSA Single Cell Genomics Pioneer Award, solidifying his global influence in single-cell biology and precision regenerative medicine.

Profiles: Scopus | Orcid

Featured Publications

"A medium throughput approach for single cell copy number variation sequencing towards efficient application in clinics", Guanchuan Lin; Caiming Chen; Mengchang Xu; Bin Peng; Zhanying Dong; Xuewen Zhou; Jinyu Gao; Jie Yu; Bei Jia; Chen Luo et al., 2025

"Causal effects of immune cell phenotypes on the risk of autoimmune liver diseases: a bidirectional two-sample Mendelian randomization study",Hongjie Zou; Xinghe Liang; Mengqi Luo; Xinghua Pan; De-Ke Jiang., 2025

"Dynamic heterogeneity towards drug resistance in AML cells is primarily driven by epigenomic mechanism unveiled by multi-omics analysis", Yulong Zhang; Yanfang Lu; Liyao Mai; Zebin Wen; Min Dai; Siwen Xu; Xianwei Lin; Yongjian Luo; Yinbin Qiu; Yuting Chen et al., 2025

"Transcriptomics-driven exploration of genetic variation and peptide discovery in the sea anemones Anthopleura midori and Actinia equina",Han Zhang; Xinghua Pan; Chen Weigang., 2025

Fang Wang | Respiratory Medicine | Best Researcher Award

Published on by Genetics and Genomics

Fang Wang | Respiratory Medicine | Best Researcher Award

Jilin University | China

Author Profile

Orcid ID

EARLY ACADEMIC PURSUITS

Professor Fang Wang’s academic journey is rooted in a strong foundation of biomedical sciences. He demonstrated a commitment to medical research early in his career, focusing on genetics and respiratory medicine. With a solid academic background and advanced education in the medical sciences, he rose through the ranks in academia to eventually become a leading figure in his field. His early interest in Mendelian genetics and inheritance patterns, combined with a scientific curiosity about regional diseases, laid the groundwork for his lifelong research pursuits.

PROFESSIONAL ENDEAVORS

Professor Fang Wang currently holds several prestigious leadership roles at Jilin University, where he serves as the Dean of the School of Basic Medicine, the Dean of the Institute of Translational Medicine, and the Dean of the Ginseng Research Institute. In addition to these leadership positions, he is also a doctoral supervisor, mentoring the next generation of medical researchers. His distinguished service has been recognized by the State Council, where he is a recipient of the Special Government Allowance, a significant national honor. During the COVID-19 pandemic, his dedication to public health and medical innovation earned him recognition as an advanced individual in the national science and technology system.

CONTRIBUTIONS AND RESEARCH FOCUS ON RESPIRATORY MEDICINE

Professor Wang’s research has primarily focused on the pathogenesis of airway diseases in cold regions and translational medicine. His work is known for bridging basic scientific findings with clinical applications, particularly in the field of respiratory medicine. A significant part of his research explores genetic and environmental interactions in respiratory disorders, especially in populations exposed to cold climates. His studies often incorporate innovative approaches in functional materials, redox biology, and drug delivery systems, contributing to both academic and clinical advancements.

IMPACT AND INFLUENCE

Over the years, Professor Wang’s work has had a substantial impact on both national and international levels. He has published more than 60 SCI-indexed articles in prominent journals such as the European Respiratory Journal, Advanced Functional Materials, Redox Biology, Respiratory Medicine, and the Journal of Controlled Release. These publications are widely cited and have influenced ongoing research in respiratory genetics, cold-region pathophysiology, and biomedical interventions. His achievements have earned him more than 10 prestigious awards, including the Chinese Medical Science and Technology Award, the Jilin Provincial Science and Technology Award, and the Jilin Provincial Science and Technology Achievement Transformation Contribution Award.

ACADEMIC CITES

Professor Fang Wang’s academic output is both prolific and impactful. His more than 60 publications in high-impact journals are frequently cited by researchers in genetics, respiratory diseases, and translational medicine. His citation record reflects the relevance and scientific merit of his research. Furthermore, his seven invention patents highlight his contributions to medical innovation and the practical application of scientific knowledge in healthcare.

LEGACY AND FUTURE CONTRIBUTIONS

Professor Wang’s legacy lies in his dual contributions to academic excellence and public health innovation. As a mentor, leader, and researcher, he has shaped institutional development at Jilin University and elevated the standard of translational research in China. Looking forward, he is poised to further contribute to global respiratory medicine, particularly through interdisciplinary research combining genetics, environmental science, and clinical therapeutics. His ongoing efforts in the transformation of scientific achievements into practical healthcare solutions are expected to leave a lasting mark on the future of medicine.

NOTABLE PUBLICATIONS

"Correction: Tang et al. Integrated Multi-Omics Analysis Reveals Mountain-Cultivated Ginseng Ameliorates Cold-Stimulated Steroid-Resistant Asthma by Regulating Interactions among Microbiota, Genes, and Metabolites." 

  • Author: Daohao Tang; Chao Wang; Hanlin Liu; Junzhe Wu; Luying Tan; Sihan Liu; Haoming Lv; Cuizhu Wang; Fang Wang; Jinping Liu
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

"Mechanisms Underlying the Therapeutic Effects of JianPiYiFei II Granules in Treating COPD Based on GEO Datasets, Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulations" 

  • Authors: Liyuan Pang; Yongjuan Zhao; Yang Xu; Chencheng Gao; Chao Wang; Xiao Yu; Fang Wang; Kan He
  • Journal: Biology
  • Year: 2024

"Integrated Multi-Omics Analysis Reveals Mountain-Cultivated Ginseng Ameliorates Cold-Stimulated Steroid-Resistant Asthma by Regulating Interactions among Microbiota, Genes, and Metabolites" 

  • Authors: Daohao Tang; Chao Wang; Hanlin Liu; Junzhe Wu; Luying Tan; Sihan Liu; Haoming Lv; Cuizhu Wang; Fang Wang; Jinping Liu
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

"The Role of Metabolomics and Microbiology in Urinary Tract Infection" 

  • Authors: Haoyu Zheng; Chao Wang; Xiao Yu; Wenxue Zheng; Yiming An; Jiaqi Zhang; Yuhan Zhang; Guoqiang Wang; Mingran Qi; Hongqiang Lin et al.
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

"PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases" 

  • Authors: Xiaoping Guo; Xu Zuo; Zhengjie Zhou; Yinuo Gu; Haoyu Zheng; Xinlei Wang; Guoqiang Wang; Caina Xu; Fang Wang
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

Yong Xu | Cartilage Tissue | Best Researcher Award

Published on by Genetics and Genomics

Dr. Yong Xu | Cartilage Tissue | Best Researcher Award

Tongji University | China

Author Profile

Scopus

✨ XU YONG: A PIONEER IN TUMOR TREATMENT AND TISSUE REPAIR ✨

🎓 EARLY ACADEMIC PURSUITS

Xu Yong was born on May 29, 1991, in Fuzhou, Jiangxi, and pursued a career in medicine from an early age. He embarked on his academic journey at Tongji University School of Medicine, where he obtained his Bachelor of Clinical Medicine (2010-2015). With a keen interest in thoracic surgery and tissue engineering, he continued his education at Shanghai Pulmonary Hospital, earning a Master's Degree in Thoracic Surgery (2015-2018). His academic dedication led him to pursue a Ph.D. in Thoracic Surgery (2018-2021) at the same institution, where he developed expertise in tumor treatment and tissue repair.

🌟 PROFESSIONAL ENDEAVORS

Following his Ph.D., Xu Yong joined Shanghai Pulmonary Hospital as a Resident Physician (2021-2024), where he honed his clinical skills in thoracic surgery and tissue engineering. In August 2024, he transitioned to a research-focused role as a Special Associate Researcher at the Nuclear Industry 416 Hospital, Provincial Clinical Medical Research Center. His work in this position is instrumental in advancing innovative solutions for tracheal tissue engineering and regenerative medicine.

⚖️ CONTRIBUTIONS AND RESEARCH FOCUS ON CARTILAGE TISSUE

Xu Yong’s research primarily revolves around tissue engineering for cartilage regeneration, with a strong emphasis on functional tracheal reconstruction. His groundbreaking work introduced the "ring strategy", which enables the construction of bionic tracheal tissue with an alternating cartilage ring-connective tissue ring arrangement. This strategy successfully demonstrated long-term functional reconstruction of long-segment tracheal defects in rabbit models.

⚛️ MAJOR RESEARCH PROJECTS

Xu Yong has been the Principal Investigator (PI) in multiple prestigious projects, including:

  • Shanghai Science and Technology Rising Star Project (2024-2027): Focused on high-bionic tracheal tissue engineering (400,000 RMB).
  • Youth Talent Support Project (2023-2025): Dedicated to tracheal tissue engineering (300,000 RMB).
  • National Natural Science Foundation of China (2024-2026): Developing simulated tracheal tissue for large animal models (300,000 RMB).
  • Shanghai Natural Science Foundation (2022-2025): Advancing the construction of bioengineered trachea (200,000 RMB).

Additionally, he is a key participant in a major project funded by the National Natural Science Foundation of China (2,150,000 RMB), focusing on the precise matching of multiple cell types for bionic construction of long-segment trachea.

✨ IMPACT AND INFLUENCE

Xu Yong’s contributions have significantly influenced the field of tissue engineering and regenerative medicine, particularly in tracheal defect repair. His innovative biomimetic tracheal tissue construction has paved the way for improved clinical applications in treating long-segment tracheal defects. His research bridges the gap between basic science and clinical translation, offering promising therapeutic solutions for thoracic surgery.

🏆 ACADEMIC CITATIONS AND PUBLICATIONS

Xu Yong has an impressive publication record, contributing to over 30 SCI papers with a cumulative impact factor exceeding 300. His key achievements include:

  • 20 papers as first/co-first author
  • 14 papers as corresponding/co-corresponding author
  • 15 papers with an impact factor greater than 10
  • Highest single impact factor: 27.4

Notable journals where his research has been published:

  • Advanced Materials (ADV MATER)
  • Advanced Functional Materials (Adv. Funct. Mater.)
  • Advanced Science (Adv Sci.)
  • Composites Part B: Engineering (COMPOS PART B-ENG)
  • International Journal of Bioprinting (INT J BIOPRINTING)

Additionally, he holds over 10 patents related to tissue engineering and regenerative medicine.

🎬 LEGACY AND FUTURE CONTRIBUTIONS

Xu Yong’s pioneering efforts in tracheal tissue engineering and tumor treatment have established a new benchmark in the field. His ring strategy has set the foundation for future research in biomimetic tracheal reconstruction. Moving forward, he aims to:

  • Advance clinical translation of biomimetic tracheal tissue into human trials.
  • Explore novel biomaterials and tissue engineering scaffolds.
  • Collaborate on interdisciplinary projects integrating AI-driven biomaterial development.

His contributions will continue to shape the future of thoracic surgery, offering lifesaving solutions for patients with severe tracheal defects.

✨ CONCLUSION

Xu Yong is a trailblazer in regenerative medicine and thoracic surgery, whose dedication to tissue engineering and tracheal reconstruction has the potential to revolutionize the field. With a solid foundation in research, clinical expertise, and a vision for innovation, he is poised to make lasting contributions to modern medicine.

📑 NOTABLE PUBLICATIONS 

"Cartilage structure-inspired nanofiber-hydrogel composite with robust proliferation and stable chondral lineage-specific differentiation function to orchestrate cartilage regeneration for artificial tracheal construction" 

  • Authors: Y., Li, Yaqiang , X., Xun, Xiaowei , L., Duan, Liang , Y., Xu, Yong , H., Xia, Huitang
  • Journal: Bioactive Materials
  • Year: 2025

"Polydopamine-loaded microneedles for sequential tumor ablation and osteochondral regeneration" 

  • Authors: B., Lin, Bin , Y., Xu, Yong , B., Liang, Bing
  • Journal: Materials Letters
  • Year: 2025

"Copper hydrogen phosphate nanosheets functionalized hydrogel with tissue adhesive, antibacterial, and angiogenic capabilities for tracheal mucosal regeneration" 

  • Authors: P., Wang, Pengli , E., Gao, Erji , T., Wang, Tao , C., Yang, Chen , L., Duan, Liang
  • Journal: Journal of Nanobiotechnology
  • Year: 2024

"3D printing of Ceffe-infused scaffolds for tailored nipple-like cartilage development" 

  • Authors: J., Ding, Jinghao , C., Wei, Chuanzhi , Y., Xu, Yong , W., Dai, Wufei , R., Chen, Ru
  • Journal: BMC Biotechnology
  • Year: 2024

"Injectable and self-healing sulfated hyaluronic acid/gelatin hydrogel as dual drug delivery system for circumferential tracheal repair" 

  • Authors: Y., Yang, Yayan , X., Zhu, Xinsheng , X., Liu, Xuezhe , N., Song, Nan , Q., Feng, Qian
  • Journal: International Journal of Biological Macromolecules
  • Year: 2024

Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Published on by Genetics and Genomics

Dr. Sang Yeon Cho | Molecular Cancer Biology | Best Researcher Award

Chungna National University | South Korea

Author Profile 

Scopus

Google Scholar

BIOGRAPHY OF SANG YEON CHO 🌟

EARLY ACADEMIC PURSUITS 🎓

Sang Yeon Cho embarked on his academic journey at Chungnam National University, where he earned his Bachelor's degree in Biochemistry in 2012. He further pursued an M.S. in Medicine, obtaining his MD degree in 2021. Currently, he is completing his Ph.D. in New Drug Discovery and Development, expected to graduate in February 2025. His strong foundation in the sciences has equipped him with the skills necessary for innovative research in the medical field.

PROFESSIONAL ENDEAVORS 🏥

Currently, Dr. Cho serves as the Vice Director of the Metro Neurosurgery Clinic in Daejeon, South Korea, since October 2022. Prior to this role, he was the Vice Director of Hurisarang Hospital from March 2021 to September 2022. His leadership positions reflect his commitment to advancing medical practice and enhancing patient care.

CONTRIBUTIONS AND RESEARCH FOCUS ON MOLECULAR CANCER BIOLOGY 🔬

As the Director of ChoLab since 2018, Dr. Cho has focused on cancer genomics and new drug discovery. His research has investigated the molecular mechanisms underlying cancer, emphasizing drug resistance and therapeutic targets. He has actively contributed to several labs, including the Neuroglia Lab and the Nano Primo Research Center, showcasing his multidisciplinary approach to tackling complex medical challenges.

IMPACT AND INFLUENCE 🌍

Dr. Cho's work has significantly influenced the field of medical genetics and cancer research. His publications in high-impact journals highlight the clinical significance of his findings, making substantial contributions to understanding cancer prognosis and treatment. Through his research, he aims to bridge the gap between laboratory discoveries and clinical applications, improving patient outcomes.

ACADEMIC CITATIONS 📚

His research output includes numerous peer-reviewed articles in respected journals such as BMC Medical Genomics, Scientific Reports, and BMC Cancer, where he explores topics like drug resistance, immunotherapy biomarkers, and cancer prognosis. His findings have garnered attention and citations within the academic community, underscoring the relevance and quality of his work.

LEGACY 🏆

Dr. Cho's dedication to advancing cancer research and patient care has already left a mark on the field. His innovative approach, exemplified by multiple patents related to AI in healthcare and cancer diagnostics, positions him as a forward-thinking researcher poised to shape future developments in medical science.

FUTURE CONTRIBUTIONS 🔮

Looking ahead, Dr. Cho aims to continue his research in cancer treatment and drug discovery, integrating cutting-edge technologies like artificial intelligence to enhance therapeutic strategies. With his expected Ph.D. completion in 2025, he is set to further expand his contributions to the field and inspire the next generation of medical researchers.

NOTABLE PUBLICATIONS 📑

"A method for the observation of the primo vascular system in the thoracic duct of a rat" 

  • Authors: Kim, S., Jung, S.J., Cho, S.Y., Soh, K.-S., Kim, S.
  • Journal: Evidence-based Complementary and Alternative Medicine
  • Year: 2013

"Protocol for the Observation of the Primo Vascular System in the Lymph Vessels of Rabbits" 

  • Authors: Jung, S.J., Cho, S.Y., Bae, K.-H., ... Song, Y.-K., Soh, K.-S.
  • Journal:  Journal of Acupuncture and Meridian Studies
  • Year: 2012